Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata

Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients

(2019) Server Serdaroğlu et al.   Dermatologic Therapy

Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study

(2018) Nawaf Almutairi et al.   DERMATOLOGY

Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis

(2017) Leslie Castelo-Soccio   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients

(2017) Lucy Y. Liu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Tofacitinib for the treatment of alopecia areata and variants in adolescents

(2017) Brittany G. Craiglow et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)

(2016) John E. Harris et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation

(2015) Eleanor Higgins et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

(2015) Ali Jabbari et al.   EBioMedicine

Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia

(2014) Lisa Pieri et al.   AMERICAN JOURNAL OF HEMATOLOGY

Alopecia Areata

(2012) Amos Gilhar et al.   NEW ENGLAND JOURNAL OF MEDICINE